title: Impact of NF-κB gene polymorphism on allograft outcome in Hispanic renal transplant recipients.
abstract: BACKGROUND
  The dimeric NF-κB transcription factors play critical roles in diverse cellular processes including adaptive and innate immunity, cell differentiation, proliferation and apoptosis. It regulates the expression of numerous genes that play a key role in the inflammatory response during kidney allograft rejection. This study aims to determine the association of NF-κB gene polymorphisms with allograft outcomes in the Hispanic renal transplant recipients.
  
  
  METHODS
  A total of 607 Hispanic renal transplant recipients at St. Vincent Medical Center between 2001 and 2010 were included in this study. The NF-κB genotypes were studied along with clinical data. In the case of NF-κB genotypes, the following single nucleotide polymorphisms (SNPs) were included: NF-κB1 (rs3774959, rs3774932, rs3774937, rs230526, rs230519), NF-κB2 (rs1056890, rs7897947, rs12769316) and NF-κB inducing kinase (NIK) (rs9908330, rs7222094). The association of each genotype with renal allograft survival and acute rejection was evaluated.
  
  
  RESULTS
  NF-κB1 (rs3774937) CC genotype showed protective association with allograft rejection (OR=0.66, 95% CI=0.44-0.99, p=0.04). There was a significant increase in allograft survival time associated with the NF-κB1 (rs3774959) A allele (OR=0.76, 95% CI=0.60-0.98, p=0.03) while GG genotype was associated with a higher risk of graft failure (OR=1.51, 95% CI=1.02-2.21, p=0.03). There were no associations between polymorphic markers in NF-κB2 and NIK genes with allograft survival or acute rejection. Among non-genetic factors, we found that the use of tacrolimus, a deceased donor, delayed graft function and acute rejection were associated with allograft failure.
  
  
  CONCLUSIONS
  The result of present study suggests that NF-κB1 gene polymorphisms may determine the incidence of acute rejection or graft survival among Hispanic allograft recipients.
authors.affiliation: Mendez National Institute of Transplantation, 2200W 3rd ST, Suite 370, Los Angeles, CA 90057, United States.
authors.forename: Don
authors.initials: D
authors.lastname: Vu
authors.forename: Eglis
authors.initials: E
authors.lastname: Tellez-Corrales
authors.forename: Prashant
authors.initials: P
authors.lastname: Sakharkar
authors.forename: Michael Scott
authors.initials: MS
authors.lastname: Kissen
authors.forename: Tariq
authors.initials: T
authors.lastname: Shah
authors.forename: Ian
authors.initials: I
authors.lastname: Hutchinson
authors.forename: David I
authors.initials: DI
authors.lastname: Min
mesh_terms: D000328:Adult; D005260:Female; D005838:Genotype; D006084:Graft Rejection / Q000453:epidemiology / Q000209:etiology / Q000235:genetics*; D006630:Hispanic or Latino / Q000706:statistics & numerical data*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000235:genetics*; D011110:Polymorphism, Genetic; D011183:Postoperative Complications / Q000453:epidemiology / Q000235:genetics*; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D016328:NF-kappa B